Rodolphe Brisset Fined, Keeneland Winner Disqualified For Medication Violation

POSTED ON  |  20-07-2019

Aminocaproic Acid
Trainer Rodolphe Brisset said a recent positive test in one of his horses for the prohibited adjunct bleeder medication aminocaproic acid was either a barn or veterinary mistake. The positive test and subsequent disqualification of Talk Veuve to Me from an April 11 allowance/optional claiming race victory at Keeneland in Lexington, Ky., was reported in Daily Racing Form.

Brisset was fined $500 and Talk Veuve to Me's owners, Team Valor International, Stephen McKay and Brisset, were ordered by stewards to forfeit the $51,000 winner's share of the $83,300 purse. Talk Veuve to me, a 4-year-old filly by Violence who won the Grade 3 Indiana Oaks in 2018 and is G1 placed, finished first as the odds-on favorite by 2 ¼ lengths in the April 11 race contested at six furlongs on dirt. Runner-up Treble was elevated to first place.

Better known as Amicar, aminocaproic acid previously had been a permitted race-day medication in a number of states, including Kentucky, whose commission changed its rules in 2012 to only permit the administration of furosemide, or Lasix, within 24 hours of a race. It is a Class 4 drug that calls for a Category C penalty (fine, but no suspension) under Association of Racing Commissioners International guidelines.

This is the first reported medication violation for Brisset, a former assistant to Patrick Biancone and Hall of Fame trainer William Mott. Brisset opened a public stable in 2017 and has won five graded stakes, including the 2019 G2 Oaklawn Handicap with Quip.

© 2015 IGSRV All rights reserved.